Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Cuspa
Cuspa Overview
Cuspa is developing an artificial cusp for use in treating aortic valve insufficiency (AI), a heart disorder in which the valve does not close properly and allows blood to flow backward into the heart. The companys CUSPER is an artificial cusp, connected to a grasper, that is attached to the native valve cusp/leaflet for the treatment of AI.
Cusper is attached to the native aortic valve cusp using a nitinol grasper, it preserves the functionality of an healthy aortic and prevents valve insuffiency. After demonstrating proof of concept, Cuspa Medical is carrying out pre-clinical studies on pigs, with the objective to optimize Cusper‘s performance.